References
- Nolan N , TeeL, VijayakumarS et al. Analytical performance validation of a coronary heart disease risk assessment multi-analyte proteomic test. Expert Opin. Med. Diagn. doi:10.1517/17530059.753055 (2012) (Epub ahead of print).
- Cross DS , McCartyCA, HytopoulosE et al. Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts. Curr. Med. Res. Opin. 28(11) , 1819–1830 (2012).
- Ackerman MJ , PrioriSG, WillemsS et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 13(8) , 1077–1109 (2011).
- Bell CJ , DinwiddieDL, MillerNA et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci. Transl. Med. 3(65) , 65ra64 (2011).
- DePristo MA , BanksE, PoplinR et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43(5) , 491–498 (2011).
▪ Website
- Aviir, Inc. www.aviir.com